Goldman Sachs Group Inc Integra Lifesciences Holdings Corp Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,306,518 shares of IART stock, worth $29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,306,518

Previous 605,121 115.91%

Holding current value

$29 Million

Previous $17.6 Million 34.63%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.14 - $31.74 $12 Million - $22.3 Million	701,397 Added 115.91%	1,306,518 $23.7 Million
Q2 2024 Aug 13, 2024	BUY	$23.14 - $34.72 $277,888 - $416,952	12,009 Added 2.02%	605,121 $17.6 Million
Q1 2024 May 15, 2024	SELL	$33.4 - $45.2 $1.97 Million - $2.67 Million	-59,042 Reduced 9.05%	593,112 $21 Million
Q4 2023 Feb 13, 2024	SELL	$34.21 - $44.59 $1.07 Million - $1.39 Million	-31,139 Reduced 4.56%	652,154 $28.4 Million
Q3 2023 May 14, 2024	BUY	$37.8 - $45.97 $1.18 Million - $1.43 Million	31,139 Added 4.77%	683,293 $26.1 Million
Q3 2023 Nov 14, 2023	BUY	$37.8 - $45.97 $2.65 Million - $3.22 Million	70,105 Added 11.43%	683,293 $26.1 Million
Q2 2023 May 14, 2024	SELL	$37.95 - $58.98 $7.17 Million - $11.1 Million	-188,902 Reduced 23.55%	613,188 $25.2 Million
Q2 2023 Aug 14, 2023	SELL	$37.95 - $58.98 $7.17 Million - $11.1 Million	-188,902 Reduced 23.55%	613,188 $25.2 Million
Q1 2023 May 14, 2024	SELL	$52.61 - $60.49 $16.6 Million - $19.1 Million	-316,288 Reduced 28.28%	802,090 $46 Million
Q1 2023 May 11, 2023	SELL	$52.61 - $60.49 $16.6 Million - $19.1 Million	-316,288 Reduced 28.28%	802,090 $46 Million
Q4 2022 May 14, 2024	BUY	$42.17 - $58.6 $5.93 Million - $8.25 Million	140,707 Added 14.39%	1,118,378 $62.7 Million
Q4 2022 Feb 13, 2023	BUY	$42.17 - $58.6 $5.93 Million - $8.25 Million	140,707 Added 14.39%	1,118,378 $62.7 Million
Q3 2022 May 14, 2024	SELL	$42.28 - $57.17 $20.7 Million - $27.9 Million	-488,541 Reduced 33.32%	977,671 $41.4 Million
Q3 2022 Nov 10, 2022	SELL	$42.28 - $57.17 $20.7 Million - $27.9 Million	-488,541 Reduced 33.32%	977,671 $41.4 Million
Q2 2022 May 14, 2024	BUY	$53.86 - $66.52 $43.8 Million - $54.2 Million	814,058 Added 124.83%	1,466,212 $79.2 Million
Q2 2022 Aug 15, 2022	SELL	$53.86 - $66.52 $2.88 Million - $3.56 Million	-53,531 Reduced 3.52%	1,466,212 $79.2 Million
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $2.33 Million - $2.56 Million	37,025 Added 2.5%	1,519,743 $97.7 Million
Q4 2021 Feb 14, 2022	BUY	$62.47 - $73.25 $39.3 Million - $46.1 Million	629,202 Added 73.72%	1,482,718 $99.3 Million
Q3 2021 Nov 10, 2021	BUY	$64.97 - $76.19 $55.5 Million - $65 Million	853,516 New	853,516 $58.4 Million

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Integra Lifesciences Holdings Corp Transaction History